Diagnosis and Management in Parkinson's Disease: The Neuroscience of Parkinson's Disease, Volume 1 (Hardcover)

Section 1: Parkinson’s Disease: Introductory Chapters? 1. A Short History of Parkinson’s Disease ? from early 19^th century and afterwards ? an overview 2. Living with Parkinson’s disease ? from financial to emotional 3. The epidemiology of Parkinson’s disease ? an overview 4. Clinical Features of Parkinson’s disease ? an overview 5. The natural history of Parkinson’s disease ? an overview 6. The prognosis of Parkinson’s disease ? an overview 7. The neurobiology of Parkinson’s disease ? an overview 8. The pathophysiology Parkinson’s disease ? an overview 9. Molecular and cellular mechanisms associated with Parkinson’s disease ? synuclein, amyloid protein, oligomers and beyond 10. Quality of life in Parkinson’s disease 11. Gait in untreated Parkinson’s disease 12. Levodopa-induced dyskinesias 13. Tremor in Parkinson’s disease 14 The impact of Parkinson’s disease on the family and careers

Section 2: Biomarkers and Diagnosis 15. Tissue biopsies as biomarkers in Parkinson’s disease 16. Spinal fluid for biomarker discovery in Parkinson’s disease 17. Clinical biomarkers in prodromal Parkinson’s disease 18. The diagnosis of Parkinson's disease 19. Proteomics in Parkinson’s disease 20. MicroRNAs as biomarkers in Parkinson’s diseases 21. Phenotyping in Parkinson’s disease 22. Diagnosis of speech disorders in Parkinson’s disease 23. Identifying dementia in Parkinson’s disease dementia 24. Diagnosis of sleep disturbances in Parkinson’s disease 25. Diagnosis of Parkinson’s disease using magnetic resonance imaging 26. Use of ultrasound as a diagnostic tool in Parkinson’s disease 27. Use of single-photon emission computerized tomography (SPECT) as a diagnostic tool in Parkinson’s disease 28. Use of positron emission tomography (PET) as a diagnostic tool in Parkinson’s disease

Section 3: Pharmacological Treatments for Parkinson’s Disease 29. Dopamine Agonists and Parkinson’s disease ? an overview 30. Management with Levodopa in Parkinson’s disease 31. Management with ripinirole in Parkinson’s disease 32. Management with pramipexole in Parkinson’s disease 33. Management with rotigotine in Parkinson’s disease 34. Management with apomorphine in Parkinson’s disease 35. Management with MAO-B Inhibitors in Parkinson’s disease 36. Management with COMT inhibitors in Parkinson’s disease 37. Management with anticholinergics in Parkinson’s disease 38. Management with amantadine in Parkinson’s disease

Section 4: Novel and Non-Pharmacological Therapies For Parkinson’s Disease 39. Treatment with chelator in Parkinson’s disease 40. Treatment with deep brain stimulation in Parkinson’s disease 41. Olive leaf extract usage as an antioxidant and applications to Parkinson’s disease 42. Treatment with Vitamin D for Parkinson’s disease 43. Chemogenetics and applications for Parkinson’s disease 44. Flavonoids and naringin usage in Parkinson’s disease 45. Stem cells and applications to Parkinson’s disease 46. Treatment with cannabis for Parkinson’s disease 47. Treating sleep problems in Parkinson’s disease 48. Perioperative treatments of Parkinsons disease 49. Exercise and Parkinson’s disease 50. Molecular aspects: CB2 receptors and neuroprotection in Parkinson’s disease